Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy

INTRODUCTION: Perampanel is a first-in-class antiepileptic drug approved for adjunctive treatment of partial-onset seizure in patients aged 12 years or older. Published randomised controlled trials (RCTs) had small sample sizes, and meta-analyses have included too few studies to draw conclusive resu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Hsu, Warrington W. Q., Sing, C. W., He, Ying, Worsley, Alan J., Wong, Ian C. K., Chan, Esther W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2013
Ämnen:
Systematic Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3784051/
https://ncbi.nlm.nih.gov/pubmed/23918722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0091-9
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk